Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
- 8 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 19 (10), 1313-1317
- https://doi.org/10.1038/nm.3362
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild caseInternational Journal of Infectious Diseases, 2013
- Pneumonia from Human Coronavirus in a Macaque ModelThe New England Journal of Medicine, 2013
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in HumansmBio, 2012
- The Hedgehog System Machinery Controls Transforming Growth Factor-β–Dependent Myofibroblastic Differentiation in HumansThe American Journal of Pathology, 2012
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaThe New England Journal of Medicine, 2012
- Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathwayMolecular Biology Reports, 2010
- Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture modelsJournal of Hepatology, 2010
- Interferon signaling and treatment outcome in chronic hepatitis CProceedings of the National Academy of Sciences of the United States of America, 2008
- Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory SyndromeJAMA, 2003
- Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.2003